Myfanwy James

Myfanwy James

Auto-generated profile, based on publicly available information

Myfanwy James

Department of International Development, London School of Economics and Political Science, London, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2022 in Medical Anthropology
Verified
Journal Article
Open access
MJMyfanwy Vaughan James
Myfanwy Vaughan James
SLShelley Susan Lees
Shelley Susan Lees
The COVID-19 pandemic began as an Ebola epidemic was unfolding in the Democratic Republic of the Congo. In this article, we examine how COVID-19 influenced experiences of an Ebola vaccine trial and attitudes towards medical research in Goma. First, critical debates about vaccine research became a forum in which to contest ineffective local governance and global inequality. Second, discussions about new COVID-19 therapeutics reignited critique of Western biomedical colonialism. Third, rumors were made powerful through everyday observations of the unexpected adaption of Ebola trial procedures in the pandemic. This illustrates the difficulties of maintaining participants’ trust, when circumstances dictate protocol alterations mid-trial.

14 March 2023 in Social Science & Medicine
Verified
Journal Article
Open access
MJMyfanwy James
Myfanwy James
JKJoseph Grace Kasereka
Joseph Grace Kasereka
BKBenjamin Kasiwa
Benjamin Kasiwa
HKHugo Kavunga-Membo
Hugo Kavunga-Membo
KKKambale Kasonia
Kambale Kasonia
SLShelley Lees
Shelley Lees
During the 10th Ebola virus disease (EVD) epidemic in the eastern Democratic Republic of the Congo (DRC) (2018-2020), two experimental EVD vaccines were deployed in North Kivu. This province has been at the centre of conflict in the region for the last 25 years. Amidst ambivalence towards protracted foreign intervention and controversy about introducing two experimental vaccines, the existing literature has focused on mistrust and 'resistance' towards the Ebola response and vaccines. In this article, we examine why people in the eastern DRC did decide to volunteer for a trial of a second EVD vaccine in North Kivu, despite the controversy. Drawing on ethnographic observation, interviews, and focus groups with trial participants conducted between September 2020 and April 2021, we analyse three motivations for participating: protection, health seeking, and expectations surrounding travel requirements. We make three points. First, participation in vaccine trials may be understood locally to have advantages which have not been considered by the trial, because they go beyond medical considerations and are specific to a particular social setting. Second, despite much of the literature focusing on a causal relationship between rumours and 'vaccine hesitancy', some rumours may in fact encourage participation. Third, material objects associated with trial participation - such as participant vaccine cards - can hold social and political meaning beyond the confines of the vaccine clinic, and influence decisions surrounding participation. Empirical investigation of how medical interventions become entangled in political economies is essential to understanding the perceived functions of participation, and thus the reasons why people volunteer in clinical trials. Participants' narratives about their decision-making provide an insight into how international bioethical debates interact with, but may also stand apart from, the situated social and economic realities driving decision-making around clinical trials on the ground. This highlights the need for ethical approaches that foreground the political, social, and economic context.

18 November 2021 in Journal of Intervention and Statebuilding
Verified
Journal Article
Open access
MJMyfanwy James
Myfanwy James
This article examines the experience of Congolese humanitarians negotiating access with armed groups in eastern DRC. It describes how humanitarians become shapeshifters: they play different roles for different audiences as a tactic of social navigation in a context of uncertainty. Because humanitarians encounter risks related to their perceived identity, they play upon identity categories and personal histories, situating themselves tactically during encounters with different armed actors through creative modes of self-fashioning. Whilst there remains a focus on performing a distinct humanitarian identity, NGOs in practice draw upon the embedded local knowledge and skills of employees to work in conflict areas.

19 January 2022 in Third World Quarterly
Verified
Journal Article
Closed access
MJMyfanwy James
Myfanwy James
This article describes how events are turned into fables in humanitarian organisations. It explores how these fables circulate, the lessons they come to embody and their influence in maintaining an organisational status quo. The article argues that such stories teach new humanitarian employees certain ‘facts’ about ‘the field’ and help form and consolidate consensus about why things are the way they are in an organisation. By describing three such fables circulating amongst Médecins Sans Frontières ‘international’ employees in the Democratic Republic of the Congo, each of which suggested a need for foreign humanitarians to maintain a certain distance from local citizens (including their nationally hired colleagues) as a means of personal and organisational security, the article illustrates how such fables can ‘justify’ certain organisational decisions that ultimately reinforce structures of unequal power relations between different humanitarian employees.

2 January 2023 in Global Public Health
Verified
Journal Article
Open access
MJMyfanwy James
Myfanwy James
AMAnthony Mansaray
Anthony Mansaray
FTFrederic Omega Thige
Frederic Omega Thige
MMMabel Mafinda
Mabel Mafinda
KKKennedy Kambale Kasonia
Kennedy Kambale Kasonia
LELuisa Enria
Luisa Enria
This article examines the experience of healthcare professionals working in primary healthcare provision during the first wave of the COVID-19 pandemic in North Kivu, the Democratic Republic of the Congo, and in Kambia District, Sierra Leone. Drawing on ethnographic observation, interviews and focus groups, we explore everyday narratives of 'crisis' in these two regions which had recently seen Ebola epidemics. In describing the impact of COVID-19 on their life, work, and relationships with patients, healthcare workers made sense of the pandemic in relation to broader experiences of structural economic and political crisis, as well as differing experiences of recent Ebola epidemics. There were contradictory experiences of rupture and continuity: whilst COVID-19 disrupted routine health provision and exacerbated tensions with patients, the pandemic was also described as continuity, interacting with broader structural problems and longer-term experiences of 'crisis'. In effect, healthcare workers experienced the COVID-19 pandemic at the crossroads between the exceptional and the everyday, where states of exception brought by emergency measures shed new light on long-standing tensions and structural crisis.

22 December 2021 in Journal of Humanitarian Affairs
Verified
Journal Article
Open access
PDF file
MJMyfanwy James
Myfanwy James
JKJoseph Grace Kasereka
Joseph Grace Kasereka
SLShelley Lees
Shelley Lees
Two experimental Ebola vaccines were deployed during the tenth Ebola epidemic (2018–20) in the Democratic Republic of the Congo (DRC). The first, the Ervebo vaccine manufactured by Merck, was used as part of a ring vaccination in the epicentre of the epidemic in North Kivu. In 2019, the prime- (Ad26.ZEBOV) and boost- (MVA-BN-Filo) vaccine manufactured by Johnson & Johnson (J&J) became the second vaccine against Ebola, deployed by the DRC-EB-001 vaccine trial in Goma, North Kivu. There was international debate as to the value and ethics of testing a second vaccine in an epidemic context. This article examines how this debate unfolded among actual and potential DRC-EB-001 trial participants in Goma. Drawing on ethnographic observation, interviews and focus groups, it explores how the trial was perceived and contested on the ground and situated in broader debates about the ethics of clinical trials, especially during the COVID-19 pandemic. We illustrate how debates around the ethics of clinical research are not simply centred on bioethical principles but are inseparable from local political dynamics and broader contests about governance, inequality and exclusion.